The invention relates to an isolated strain of Lactobacillus crispatus, identified as IP174178 and deposited at the CNCM under number I-4646 or an isolated strain having the same characteristics as IP174178. The invention also relates to a pharmaceutical composition or a nutraceutical composition comprising such a strain, and to the use thereof for the treatment or prevention of genital infections.
